Published Studies Related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)
Well-designed clinical trials related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)
Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. [2010.07]
Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood
pressure in geriatric hypertension. [2010]
Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker. [2009.11]
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. [2008.03]
The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. [2004.05]
Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. [2002.02]
A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects. [1993.04]
Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension. [1991.05]
Effect of spironolactone-hydrochlorothiazide on lung function in infants with chronic bronchopulmonary dysplasia. [1989.04]
Well-designed clinical trials possibly related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)
Pharmacotherapy review of chronic pediatric hypertension. [2011.10]
Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension. [2010.05]
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. [2008.09]
Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial. [2008.04.17]
Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. [2007.07]
Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. [2007.05]
Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. [2007.01.11]
Effect of various diuretic treatments on rosiglitazone-induced fluid retention. [2006.12]
Effects of eplerenone versus losartan in patients with low-renin hypertension. [2005.09]
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. [2005.08]
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. [2003.10.14]
Comparison of two oral electrolyte solutions for the treatment of dehydrated calves with experimentally-induced diarrhoea. [2001.09]
The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension. [1997.05]
A randomized comparison of the effect of two diuretics, a converting enzyme inhibitor, and a sympathomimetic amine on weight loss in diet-refractory patients. [1995.09]
Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. [1989.10]
Other research related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. [2010.05]
[Impact of patient compliance on the outcomes in hypertensive patients receiving hydrochlorothiazide based combination therapy with spironolactone or captopril.] [2008.12]
Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension. [1988.11.15]
Other possibly related research studies
Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension. [2007.01]
The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters. [2006.06]
Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. [2006.01]
Regression of existing glomerulosclerosis by inhibition of aldosterone. [2005.11]
[A patient with severe hyperkalaemia -- an emergency after RALES] [2005.09.09]
Aldosterone antagonism: an emerging strategy for effective blood pressure lowering. [2005.06]
A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2005]
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. [2004.06]
A reliable, practical, and economical protocol for inducing diarrhea and severe dehydration in the neonatal calf. [1998.07]
Clinical and laboratory assessment of hydration status of neonatal calves with diarrhea. [1998.04.01]
Hyperkalaemia and diarrhoea in a patient with surreptitious ingestion of potassium sparing diuretics. [1997.10]
Are prescribing patterns of diuretics in general practice good enough? A report from the More & Romsdal Prescription Study. [1997.03]
Serum lipoproteins during treatment with antihypertensive drugs. [1993]
Effect of diuretics on the plasma lipid profile. [1992.12]
Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. [1992.04]
Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. [1991.09]
[Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites] [1989.08.01]
[Respiratory insufficiency in mucoviscidosis. Pathophysiologic aspects of conservative drug therapy] [1989.01]
Mineral excretion in premature infants receiving various diuretic therapies. [1988.09]
Clinical implications of primary aldosteronism with resistant hypertension. [1988.02]
[Studies on the bioequivalence of canrenone using pharmacokinetic data and clinical effects] [1987.09.15]
Update of diuretics in the treatment of hypertension. [2007.03]
Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2007]
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. [2007.09]
Metabolic syndrome: treatment of hypertensive patients. [2007.07]
Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies. [2007]
Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. [2008.07]
Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes. [2009.08.08]
Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. [2008.11]
Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes. [2009.12]
Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure. [2011.09.30]
Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension. [2011.04.15]
Impact of aldosterone receptor blockade compared with thiazide therapy on
sympathetic nervous system function in geriatric hypertension. [2010]
Mineralocorticoid receptor blockade improves coronary microvascular function in
individuals with type 2 diabetes. [2015]
|